Navigation Links
Life Sciences Discovery Fund announces $3.7m in research and development grants

SEATTLE, Washington, September 13, 2013 For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today. Also announced was $2.4M in Opportunity grants for two major research and development initiatives. (See Backgrounder Information.)

The LSDF Board of Trustees made the final award selections following review of proposals for scientific and technical merit, potential impact on health and health care in Washington, and future economic and commercial returns to the state.

The five Proof of Concept grants will advance products to improve the prevention, diagnosis, or treatment of Alzheimer's disease, brain cancer, and tooth decay. Funding will also support technology to increase biomedical research productivity and enable development of safer drugs.

"This latest set of Proof of Concept awards is our final cohort for the 2012-2013 funding cycle, and we are thrilled to close this cycle on such a high note," said John DesRosier, LSDF executive director. "These grants will foster commercialization of novel technologies directed at specific diseases such as Alzheimer's, as well as at cutting-edge tools with the potential to enhance research and drug development for many diseases, in Washington and beyond."

The Opportunity grants to the Seattle Children's Research Institute (SCRI) and the University of Washington (UW) support initiatives that significantly leverage LSDF dollars against funds from other sources. Funding for both grants is contingent upon receipt of the leveraged commitments described in the proposals.

The SCRI award will fund critical studies of a cancer immunotherapy regimen that is in clinical trials in children and adults, in support of principal investigator Michael Jensen's vision to develop a leading immunotherapy program in Seattle. SCRI and partners will match the LSDF dollars through grants and philanthropic donations.

The UW award will support the launch of the Institute for Protein Design and the development and commercialization of medically useful proteins from the laboratory of principal investigator David Baker. LSDF funding will be matched by contributions from UW and private donors.

"These Opportunity grants, to two of our state's top research institutions, will help Washington maintain its leadership position in cancer research and treatment and capitalize upon the outputs of some of our most innovative and productive investigators," noted board chair Carol Dahl.


Contact: Cathyryne Manner
Life Sciences Discovery Fund

Related medicine news :

1. UAS LifeSciences Launches New Brand at Expo East
2. New Name, Same Commitment to Advancing the Neurological Sciences: The Movement Disorder Society (MDS) Becomes the International Parkinson and Movement Disorder Society
3. Western University of Health Sciences to Welcome More Than 1,100 New Students
4. AxoGen, Inc. to Present at the Wedbush 2013 Life Sciences Management Access Conference
5. Patheon’s Michael Lehmann Named Among PharmaVOICE 100 List of Most Inspiring People in Life Sciences Industry
6. Scott Sheldon – Specialist in Healthcare and Life Sciences Supply Chain & Official Sponsor of LogiPharma 2013
7. Market Publishers Ltd and Select Biosciences Sign Partnership Agreement
8. CMUs Kathryn Roeder to receive Outstanding Achievement by a Woman in Statistical Sciences award
9. AKA Enterprise Solutions Launches CRM and ERP Web Site for Life Sciences
10. Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinsons disease
11. esyringe® Celebrates Expansion in Life Sciences Sector
Post Your Comments:
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: